ID BLH1_YEAST Reviewed; 483 AA. AC Q01532; D6W0V4; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 26-JUN-2007, sequence version 3. DT 27-MAR-2024, entry version 204. DE RecName: Full=Cysteine proteinase 1, mitochondrial; DE EC=3.4.22.40; DE AltName: Full=Bleomycin hydrolase; DE Short=BLM hydrolase; DE AltName: Full=Homocysteine-thiolactonase; DE Short=HTLase; DE Short=Hcy-thiolactonase; DE AltName: Full=Leucine aminopeptidase 3; DE AltName: Full=Y3; DE Flags: Precursor; GN Name=LAP3; Synonyms=BLH1, GAL6, YCP1; OrderedLocusNames=YNL239W; GN ORFNames=N1118; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], BIOPHYSICOCHEMICAL PROPERTIES, AND RP ACTIVITY REGULATION. RX PubMed=1400467; DOI=10.1016/s0021-9258(19)36648-7; RA Kambouris N.G., Burke D.J., Creutz C.E.; RT "Cloning and characterization of a cysteine proteinase from Saccharomyces RT cerevisiae."; RL J. Biol. Chem. 267:21570-21576(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 228-250 AND RP 367-387. RX PubMed=8424954; DOI=10.1016/0167-4781(93)90069-p; RA Magdolen U., Mueller G., Magdolen V., Bandlow W.; RT "A yeast gene (BLH1) encodes a polypeptide with high homology to vertebrate RT bleomycin hydrolase, a family member of thiol proteinases."; RL Biochim. Biophys. Acta 1171:299-303(1993). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], BIOPHYSICOCHEMICAL PROPERTIES, AND RP ACTIVITY REGULATION. RX PubMed=8463237; DOI=10.1016/s0021-9258(18)53142-2; RA Enenkel C., Wolf D.H.; RT "BLH1 codes for a yeast thiol aminopeptidase, the equivalent of mammalian RT bleomycin hydrolase."; RL J. Biol. Chem. 268:7036-7043(1993). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8896273; RX DOI=10.1002/(sici)1097-0061(199609)12:10b<1071::aid-yea4>3.0.co;2-s; RA Pandolfo D., de Antoni A., Lanfranchi G., Valle G.; RT "The DNA sequence of cosmid 14-5 from chromosome XIV reveals 21 open RT reading frames including a novel gene encoding a globin-like domain."; RL Yeast 12:1071-1076(1996). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169873; RA Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K., RA Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K., RA Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M., RA Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F., RA Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F., Doignon F., RA Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M., Fritz C., RA Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N., Goffeau A., RA Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D., Hilbert H., RA Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A., Jonniaux J.-L., RA Karpfinger-Hartl L., Lanfranchi G., Lepingle A., Levesque H., Lyck R., RA Maftahi M., Mallet L., Maurer C.T.C., Messenguy F., Mewes H.-W., Moestl D., RA Nasr F., Nicaud J.-M., Niedenthal R.K., Pandolfo D., Pierard A., RA Piravandi E., Planta R.J., Pohl T.M., Purnelle B., Rebischung C., RA Remacha M.A., Revuelta J.L., Rinke M., Saiz J.E., Sartorello F., RA Scherens B., Sen-Gupta M., Soler-Mira A., Urbanus J.H.M., Valle G., RA Van Dyck L., Verhasselt P., Vierendeels F., Vissers S., Voet M., RA Volckaert G., Wach A., Wambutt R., Wedler H., Zollner A., Hani J.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV and its RT evolutionary implications."; RL Nature 387:93-98(1997). RN [6] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [7] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-58, MASS SPECTROMETRY, AND RP MUTAGENESIS OF CYS-102 AND 271-LYS--LYS-274. RX PubMed=9374524; DOI=10.1074/jbc.272.48.30350; RA Zheng W., Xu H.E., Johnston S.A.; RT "The cysteine-peptidase bleomycin hydrolase is a member of the galactose RT regulon in yeast."; RL J. Biol. Chem. 272:30350-30355(1997). RN [8] RP PROTEIN SEQUENCE OF 228-251 AND 367-387. RX PubMed=1882548; DOI=10.1002/yea.320070305; RA Creutz C.E., Snyder S.L., Kambouris N.G.; RT "Calcium-dependent secretory vesicle-binding and lipid-binding proteins of RT Saccharomyces cerevisiae."; RL Yeast 7:229-244(1991). RN [9] RP PROTEIN SEQUENCE OF C-TERMINUS, X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF RP 30-483, AND SUBUNIT. RX PubMed=7638617; DOI=10.1126/science.7638617; RA Joshua-Tor L., Xu H.E., Johnston S.A., Rees D.C.; RT "Crystal structure of a conserved protease that binds DNA: the bleomycin RT hydrolase, Gal6."; RL Science 269:945-950(1995). RN [10] RP DNA-BINDING, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=8063738; DOI=10.1016/s0021-9258(17)31945-2; RA Xu H.E., Johnston S.A.; RT "Yeast bleomycin hydrolase is a DNA-binding cysteine protease. RT Identification, purification, biochemical characterization."; RL J. Biol. Chem. 269:21177-21183(1994). RN [11] RP DNA-BINDING, AND SUBCELLULAR LOCATION. RX PubMed=9584198; DOI=10.1128/mcb.18.6.3580; RA Zheng W., Johnston S.A.; RT "The nucleic acid binding activity of bleomycin hydrolase is involved in RT bleomycin detoxification."; RL Mol. Cell. Biol. 18:3580-3585(1998). RN [12] RP FUNCTION. RX PubMed=12555812; DOI=10.1139/o02-167; RA Wang H., Ramotar D.; RT "Cellular resistance to bleomycin in Saccharomyces cerevisiae is not RT affected by changes in bleomycin hydrolase levels."; RL Biochem. Cell Biol. 80:789-796(2002). RN [13] RP SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]. RX PubMed=14562095; DOI=10.1038/nature02026; RA Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., RA Weissman J.S., O'Shea E.K.; RT "Global analysis of protein localization in budding yeast."; RL Nature 425:686-691(2003). RN [14] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [15] RP SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]. RC STRAIN=ATCC 76625 / YPH499; RX PubMed=14576278; DOI=10.1073/pnas.2135385100; RA Sickmann A., Reinders J., Wagner Y., Joppich C., Zahedi R.P., Meyer H.E., RA Schoenfisch B., Perschil I., Chacinska A., Guiard B., Rehling P., RA Pfanner N., Meisinger C.; RT "The proteome of Saccharomyces cerevisiae mitochondria."; RL Proc. Natl. Acad. Sci. U.S.A. 100:13207-13212(2003). RN [16] RP FUNCTION, AND MUTAGENESIS OF HIS-398. RX PubMed=16769724; DOI=10.1074/jbc.m603656200; RA Zimny J., Sikora M., Guranowski A., Jakubowski H.; RT "Protective mechanisms against homocysteine toxicity: the role of bleomycin RT hydrolase."; RL J. Biol. Chem. 281:22485-22492(2006). RN [17] RP ALTERNATIVE INITIATION. RX PubMed=17101987; DOI=10.1073/pnas.0605645103; RA Miura F., Kawaguchi N., Sese J., Toyoda A., Hattori M., Morishita S., RA Ito T.; RT "A large-scale full-length cDNA analysis to explore the budding yeast RT transcriptome."; RL Proc. Natl. Acad. Sci. U.S.A. 103:17846-17851(2006). RN [18] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [19] RP X-RAY CRYSTALLOGRAPHY (1.87 ANGSTROMS) OF 30-483 OF MUTANT ALA-102, AND RP MUTAGENESIS OF GLY-479. RX PubMed=9546396; DOI=10.1016/s0092-8674(00)81150-2; RA Zheng W., Johnston S.A., Joshua-Tor L.; RT "The unusual active site of Gal6/bleomycin hydrolase can act as a RT carboxypeptidase, aminopeptidase, and peptide ligase."; RL Cell 93:103-109(1998). CC -!- FUNCTION: The normal physiological role of the enzyme is unknown, but CC it is not essential for the viability of yeast cells. Has CC aminopeptidase activity, shortening substrate peptides sequentially by CC 1 amino acid. Has bleomycin hydrolase activity, which can protect the CC cell from the toxic effects of bleomycin. Has homocysteine- CC thiolactonase activity, protecting the cell against homocysteine CC toxicity. Acts as a repressor in the GAL4 regulatory system, but this CC does not require either the peptidase or nucleic acid-binding CC activities. {ECO:0000269|PubMed:12555812, ECO:0000269|PubMed:16769724}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Inactivates bleomycin B2 (a cytotoxic glycometallopeptide) by CC hydrolysis of a carboxyamide bond of beta-aminoalanine, but also CC shows general aminopeptidase activity. The specificity varies CC somewhat with source, but amino acid arylamides of Met, Leu and Ala CC are preferred.; EC=3.4.22.40; CC -!- ACTIVITY REGULATION: Inhibited by E64, a specific inhibitor of cysteine CC proteases, N-ethylmaleimide, iodacetamide, and mercury and zinc ions. CC {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8463237}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=12.8 uM for arginine-4-methyl-7-coumarylamide CC {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738, CC ECO:0000269|PubMed:8463237}; CC KM=0.33 mM for glutamine-beta-naphthylamide CC {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738, CC ECO:0000269|PubMed:8463237}; CC KM=228 uM for lysine-4-methyl-7-coumarylamide CC {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738, CC ECO:0000269|PubMed:8463237}; CC Vmax=2.56 umol/h/mg enzyme for arginine-4-methyl-7-coumarylamide CC {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738, CC ECO:0000269|PubMed:8463237}; CC Vmax=370 nmol/min/mg enzyme for glutamine-beta-naphthylamide CC {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738, CC ECO:0000269|PubMed:8463237}; CC Note=N-terminal acetylation of lysine-4-methyl-7-coumarylamide CC (Ac-Lys-AMC) reduces the catalytic efficiency 50-fold towards this CC substrate.; CC pH dependence: CC Optimum pH is 7.5. {ECO:0000269|PubMed:1400467, CC ECO:0000269|PubMed:8063738, ECO:0000269|PubMed:8463237}; CC -!- SUBUNIT: Homohexamer. Binds to nucleic acids. Binds single-stranded DNA CC and RNA with higher affinity than double-stranded DNA. CC {ECO:0000269|PubMed:7638617}. CC -!- SUBCELLULAR LOCATION: [Isoform Cytoplasmic]: Cytoplasm. CC -!- SUBCELLULAR LOCATION: [Isoform Mitochondrial]: Mitochondrion. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative initiation; Named isoforms=2; CC Name=Mitochondrial; CC IsoId=Q01532-1; Sequence=Displayed; CC Name=Cytoplasmic; CC IsoId=Q01532-2; Sequence=VSP_026453; CC -!- PTM: The N-terminus of isoform Cytoplasmic is blocked. CC -!- MASS SPECTROMETRY: Mass=51830; Method=Electrospray; CC Evidence={ECO:0000269|PubMed:9374524}; CC -!- MISCELLANEOUS: Present with 521 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- MISCELLANEOUS: [Isoform Cytoplasmic]: Produced by alternative CC initiation at Met-30 of isoform Mitochondrial. {ECO:0000305}. CC -!- SIMILARITY: Belongs to the peptidase C1 family. {ECO:0000255|PROSITE- CC ProRule:PRU10088, ECO:0000255|PROSITE-ProRule:PRU10089}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M97910; AAA35231.1; -; Genomic_DNA. DR EMBL; X69124; CAA48878.1; -; Genomic_DNA. DR EMBL; X68228; CAA48309.1; -; Genomic_DNA. DR EMBL; Z71515; CAA96144.1; -; Genomic_DNA. DR EMBL; Z69381; CAA93359.1; -; Genomic_DNA. DR EMBL; U74299; AAB18260.1; -; Genomic_DNA. DR EMBL; BK006947; DAA10320.1; -; Genomic_DNA. DR PIR; A46093; S25606. DR RefSeq; NP_014160.2; NM_001183077.1. [Q01532-2] DR PDB; 1A6R; X-ray; 2.05 A; A=32-483. DR PDB; 1GCB; X-ray; 2.20 A; A=30-483. DR PDB; 2DZY; X-ray; 2.57 A; A=30-482. DR PDB; 2DZZ; X-ray; 2.15 A; A=30-482. DR PDB; 2E00; X-ray; 2.00 A; A=30-482. DR PDB; 2E01; X-ray; 1.73 A; A=30-482. DR PDB; 2E02; X-ray; 2.20 A; A=30-482. DR PDB; 2E03; X-ray; 2.13 A; A=30-482. DR PDB; 3GCB; X-ray; 1.87 A; A=30-482. DR PDBsum; 1A6R; -. DR PDBsum; 1GCB; -. DR PDBsum; 2DZY; -. DR PDBsum; 2DZZ; -. DR PDBsum; 2E00; -. DR PDBsum; 2E01; -. DR PDBsum; 2E02; -. DR PDBsum; 2E03; -. DR PDBsum; 3GCB; -. DR AlphaFoldDB; Q01532; -. DR SMR; Q01532; -. DR BioGRID; 35600; 54. DR DIP; DIP-2941N; -. DR IntAct; Q01532; 11. DR MINT; Q01532; -. DR STRING; 4932.YNL239W; -. DR MEROPS; C01.085; -. DR iPTMnet; Q01532; -. DR MaxQB; Q01532; -. DR PaxDb; 4932-YNL239W; -. DR PeptideAtlas; Q01532; -. DR EnsemblFungi; YNL239W_mRNA; YNL239W; YNL239W. [Q01532-2] DR GeneID; 855482; -. DR KEGG; sce:YNL239W; -. DR AGR; SGD:S000005183; -. DR SGD; S000005183; LAP3. DR eggNOG; KOG4128; Eukaryota. DR GeneTree; ENSGT00390000001735; -. DR HOGENOM; CLU_038600_0_1_1; -. DR InParanoid; Q01532; -. DR OMA; DDGGWWQ; -. DR OrthoDB; 45184at2759; -. DR BioCyc; YEAST:G3O-33237-MONOMER; -. DR BRENDA; 3.4.13.23; 984. DR BRENDA; 3.4.22.40; 984. DR Reactome; R-SCE-983168; Antigen processing: Ubiquitination & Proteasome degradation. DR SABIO-RK; Q01532; -. DR BioGRID-ORCS; 855482; 0 hits in 10 CRISPR screens. DR EvolutionaryTrace; Q01532; -. DR PRO; PR:Q01532; -. DR Proteomes; UP000002311; Chromosome XIV. DR RNAct; Q01532; Protein. DR GO; GO:0005737; C:cytoplasm; IDA:SGD. DR GO; GO:0005739; C:mitochondrion; HDA:SGD. DR GO; GO:0004177; F:aminopeptidase activity; IBA:GO_Central. DR GO; GO:0070005; F:cysteine-type aminopeptidase activity; IEA:InterPro. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:UniProtKB-EC. DR GO; GO:0008234; F:cysteine-type peptidase activity; IDA:SGD. DR GO; GO:0003690; F:double-stranded DNA binding; IDA:SGD. DR GO; GO:0003729; F:mRNA binding; IDA:SGD. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:SGD. DR GO; GO:0003697; F:single-stranded DNA binding; IDA:SGD. DR GO; GO:0043418; P:homocysteine catabolic process; IDA:SGD. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:SGD. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0046677; P:response to antibiotic; IDA:SGD. DR GO; GO:0009636; P:response to toxic substance; IBA:GO_Central. DR CDD; cd00585; Peptidase_C1B; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 1. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR000169; Pept_cys_AS. DR InterPro; IPR025660; Pept_his_AS. DR InterPro; IPR004134; Peptidase_C1B. DR PANTHER; PTHR10363; BLEOMYCIN HYDROLASE; 1. DR PANTHER; PTHR10363:SF2; BLEOMYCIN HYDROLASE; 1. DR Pfam; PF03051; Peptidase_C1_2; 1. DR PIRSF; PIRSF005700; PepC; 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR PROSITE; PS00139; THIOL_PROTEASE_CYS; 1. DR PROSITE; PS00639; THIOL_PROTEASE_HIS; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative initiation; Cytoplasm; Direct protein sequencing; KW DNA-binding; Hydrolase; Mitochondrion; Protease; Reference proteome; KW Thiol protease; Transit peptide. FT TRANSIT 1..30 FT /note="Mitochondrion" FT /evidence="ECO:0000255" FT CHAIN 31..482 FT /note="Cysteine proteinase 1, mitochondrial" FT /id="PRO_0000050554" FT PROPEP 483 FT /note="Removed in mature form; by autocatalysis" FT /evidence="ECO:0000269|PubMed:7638617" FT /id="PRO_0000292865" FT ACT_SITE 102 FT ACT_SITE 398 FT ACT_SITE 421 FT VAR_SEQ 1..29 FT /note="Missing (in isoform Cytoplasmic)" FT /evidence="ECO:0000305" FT /id="VSP_026453" FT MUTAGEN 102 FT /note="C->A: Abolishes peptidase activity, which also FT hinders autocatalytic processing of the enzyme to the FT mature form." FT /evidence="ECO:0000269|PubMed:9374524" FT MUTAGEN 271..274 FT /note="KDKK->ADAA: In GAL6DB; disrupts nucleic acid-binding FT activity, but retains normal peptidase activity." FT /evidence="ECO:0000269|PubMed:9374524" FT MUTAGEN 398 FT /note="H->A: Abolishes Hcy-thiolactonase activity." FT /evidence="ECO:0000269|PubMed:16769724" FT MUTAGEN 479 FT /note="G->A: Results in the abnormal cleavage of 3 FT C-terminal residues instead of only 1 during autocatalytic FT processing." FT /evidence="ECO:0000269|PubMed:9546396" FT CONFLICT 187 FT /note="I -> M (in Ref. 2; CAA48878)" FT /evidence="ECO:0000305" FT HELIX 36..47 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 50..59 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 64..68 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 71..77 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 83..85 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 98..100 FT /evidence="ECO:0007829|PDB:3GCB" FT HELIX 102..118 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 128..149 FT /evidence="ECO:0007829|PDB:2E01" FT TURN 150..152 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 158..165 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 174..184 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 189..191 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 197..200 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 203..226 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 229..231 FT /evidence="ECO:0007829|PDB:1A6R" FT HELIX 232..252 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 264..269 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 275..280 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 282..288 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 296..301 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 311..314 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 326..330 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 333..345 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 350..354 FT /evidence="ECO:0007829|PDB:2E01" FT TURN 356..359 FT /evidence="ECO:0007829|PDB:2E01" FT TURN 362..365 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 374..377 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 385..390 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 398..407 FT /evidence="ECO:0007829|PDB:2E01" FT TURN 409..411 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 414..420 FT /evidence="ECO:0007829|PDB:2E01" FT TURN 425..428 FT /evidence="ECO:0007829|PDB:2E03" FT STRAND 432..436 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 437..443 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 444..450 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 451..453 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 456..463 FT /evidence="ECO:0007829|PDB:2E01" FT STRAND 470..472 FT /evidence="ECO:0007829|PDB:2E01" FT HELIX 477..479 FT /evidence="ECO:0007829|PDB:1A6R" SQ SEQUENCE 483 AA; 55483 MW; BF92A6049F98DD3D CRC64; MLPTSVSRSL YLKTFRSHLL RAPQIVLKRM SSSIDISKIN SWNKEFQSDL THQLATTVLK NYNADDALLN KTRLQKQDNR VFNTVVSTDS TPVTNQKSSG RCWLFAATNQ LRLNVLSELN LKEFELSQAY LFFYDKLEKA NYFLDQIVSS ADQDIDSRLV QYLLAAPTED GGQYSMFLNL VKKYGLIPKD LYGDLPYSTT ASRKWNSLLT TKLREFAETL RTALKERSAD DSIIVTLREQ MQREIFRLMS LFMDIPPVQP NEQFTWEYVD KDKKIHTIKS TPLEFASKYA KLDPSTPVSL INDPRHPYGK LIKIDRLGNV LGGDAVIYLN VDNETLSKLV VKRLQNNKAV FFGSHTPKFM DKKTGVMDIE LWNYPAIGYN LPQQKASRIR YHESLMTHAM LITGCHVDET SKLPLRYRVE NSWGKDSGKD GLYVMTQKYF EEYCFQIVVD INELPKELAS KFTSGKEEPI VLPIWDPMGA LAK //